Physician profile
Shanna M Morgan
NPI 1215071675
$631,476.36
in general payments reported to CMS, 2019-2025
4 companies · $106K in 2025
The $106K reported for 2025 was more than what 99% of Anatomic Pathology & Clinical Pathology providers received nationally (typical 2025 total: $50.59).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66K · 2020: $70K · 2021: $84K · 2022: $100K · 2023: $106K · 2024: $100K · 2025: $106K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $311K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $311,460.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $320,000.00 | 2019-2022 | |
| Csl Plasma INC. | $310,560.00 | 2023-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $900.00 | 2025 | |
| Genzyme Corporation | $16.36 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shanna Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.